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A B S T R A C T
The etiology of schizophrenia is multi-factorial with early neurodevelopmental antecedents, likely to result from
a complex interaction of genetic and environmental risk. However, few studies have examined how schizo-
phrenia polygenic risk scores (PRS) are moderated by environmental factors in shaping neurodevelopmental
brain structure, prior to the onset of psychotic symptoms. Here, we examined whether hair cortisol, a quanti-
tative metric of chronic stress, moderated the association between genetic risk for schizophrenia and pre-ado-
lescent brain structure.
This study was embedded within the Generation R Study, involving pre-adolescents of European ancestry
assessed regarding schizophrenia PRS, hair cortisol, and brain imaging (n=498 structural; n=526 diﬀusion
tensor imaging). Linear regression was performed to determine the association between schizophrenia PRS, hair
cortisol level, and brain imaging outcomes.
Although no single measure exceeded the multiple testing threshold, nominally signiﬁcant interactions were
observed for total ventricle volume (P interaction = 0.02) and global white matter microstructure (P interaction =
0.01) – two of the most well replicated brain structural ﬁndings in schizophrenia.
These ﬁndings provide suggestive evidence for the joint eﬀects of schizophrenia liability and cortisol levels on
brain correlates in the pediatric general population. Given the widely replicated ﬁnding of ventricular en-
largement and lower white matter integrity among schizophrenia patients, our ﬁndings generate novel hy-
potheses for future research on gene-environment interactions aﬀecting the neurodevelopmental pathophy-
siology of schizophrenia.
1. Introduction
Schizophrenia is a highly heritable psychiatric disorder, mediated
through a complex combination of common and rare genetic variants
(Sullivan et al., 2003). In addition to genetic risk, there is substantial
epidemiological evidence for the eﬀects of several environmental
determinants on the risk of schizophrenia, including chronic cannabis
use (Marconi et al., 2016), obstetric complications (Cannon et al.,
2002), ethnic minority status (Bourque et al., 2011), urbanicity (Vassos
et al., 2012) and stressful life events (Belbasis et al., 2018). Given
maximum heritability estimates of ˜80% based on twin heritability es-
timates (Hilker et al., 2018), the genetic liability of schizophrenia
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appears to be at least partially moderated by environmental determi-
nants (van Os et al., 2010).
Polygenic risk scores (PRS) are derived as the weighted sum of risk
alleles derived from genome-wide association studies (GWAS) (Wray
et al., 2014). Several studies have employed schizophrenia PRS to in-
vestigate developmental manifestations of increased genetic liability for
schizophrenia in the general population (Mistry et al., 2017). The
schizophrenia PRS has been associated with early life emotional and
behavioral problems (Jones et al., 2016), cognition (Riglin et al., 2017),
and physical health problems(Stringer et al., 2014) in the general po-
pulation. Increasingly, PRS for schizophrenia are employed in imaging
genetics studies to assess underlying brain correlates of vulnerability to
schizophrenia (Bogdan et al., 2017; Dima and Breen, 2015). Previous
studies have reported associations of schizophrenia PRS with total brain
volume and gyriﬁcation indices (Caseras et al., 2015; Liu et al., 2017;
Terwisscha van Scheltinga et al., 2013), though several null ﬁndings
have also been published (Papiol et al., 2014; Van der Auwera et al.,
2015, 2017). Studies that assess how genetic risk for schizophrenia is
related to variations in structural brain correlates are important, given
that both gray matter and white matter microstructural correlates have
been consistently observed in patients with schizophrenia (Brugger and
Howes, 2017; Kelly et al., 2018; van Erp et al., 2016, 2018), and this
has also been replicated in childhood-onset schizophrenia samples
(Tamnes and Agartz, 2016) and ﬁrst-episode psychosis patients (Fusar-
Poli et al., 2014). However, no prior studies have assessed the inter-
action between genetic and stress-related environmental risk factors on
childhood brain development, despite that schizophrenia pathophy-
siology is widely hypothesized to have early neurodevelopmental
antecedents that are sensitive to the environmental stressors (van Os
et al., 2010).
Here, in a population-based sample of ten-year-olds, an age well
before the clinical onset of overt psychotic psychopathology, we used
PRS as an index of genetic vulnerability to schizophrenia
(Schizophrenia Working Group of the Psychiatric Genomics
Consortium, 2014). Cortisol levels were measured through hair analysis
as a naturalistic quantitative metric of chronic physiological stress. In
the recent years, hair cortisol has been increasingly studied as a bio-
logical marker of chronic physiological stress. Hair cortisol indicates
long-term exposure to stress and, due to the hair’s natural speed of
growth, one centimeter of hair represents one month of cortisol ex-
posure (Noppe et al., 2015). In the current study, we obtained hair
samples of 3 cm in length – reﬂecting three months of cortisol exposure.
Moreover, recent studies have demonstrated that hair cortisol levels are
indicative of more chronic stress exposure and exhibit high intra-sub-
ject temporal stability (Stalder et al., 2017, 2012). Our primary aim was
to examine whether chronic stress, as operationally deﬁned by hair
cortisol levels, moderated the relationship between schizophrenia PRS
and pre-adolescent structural brain correlates. Our hypotheses focused
on brain outcomes which have most consistently been associated with
the underlying neurobiology of schizophrenia – cortical and subcortical
gray matter (van Erp et al., 2016, 2018), cerebroventricular volume
(van Erp et al., 2016) and white matter microstructure (Kelly et al.,
2018). We expected that, among children with an elevated genetic
liability to schizophrenia, high cortisol levels would be associated with
lower (sub-)cortical gray matter volume, larger ventricles and de-
creased white matter microstructure..
2. Methods
2.1. Study population
The present study was embedded within the Generation R Study, a
prospective population-based birth cohort from Rotterdam, the
Netherlands. The aim of the Generation R Study is to identify genetic
and environmental determinants that inﬂuence maternal and child
development (Kooijman et al., 2016). For the current study, 2512
children of European descent (based on genetic ancestry; 53% of
n=4780 participants of European descent who were eligible for the
age ten years wave) had genotype data available. Hair samples were
collected in an un-selected sub-sample of the Generation R cohort at
mean age six years. At mean age ten years, participants were invited for
a brain magnetic resonance imaging (MRI) scan, of whom n=593
consented for participation in the current study. After standardized
quality control procedures, the ﬁnal sample comprised 498 children for
T1 and 526 for diﬀusion tensor imaging (DTI) analyses, respectively
(Appendix Figure A.1 for a ﬂowchart). Study protocols were approved
by the Medical Ethics Committee of the Erasmus Medical Center. All
participants and their parents provided assent and informed consent,
respectively.
2.2. Attrition analysis
Comparisons were made between the study sample (N=498) and
participants who were genotyped but without hair cortisol or brain
morphology data (N=2512). These groups did not diﬀer in proportion
of girls (47.2% versus 49.9%, χ2= 1.07, df=1, P=0.30) or in mean
schizophrenia PRS (Pt < 0.0005; 0.01 versus -0.01, t=-0.59, P=0.56).
However, children with complete data were more likely to have mo-
thers with higher educational levels (79.5% versus 70.5%, χ2= 14.68,
df=1, P < 0.01).
2.3. Genotyping and quality control
Genotype quality control procedures for the Generation R Study
were performed as previously described (Medina-Gomez et al., 2015).
Brieﬂy, genotype data were collected from either cord blood at birth
(Illumina 610 K Quad Chip) or from whole venous blood collected
during a follow-up visit (Illumina 660k Quad Chip). Variants were in-
cluded if they passed sample (≥97.5%) and SNP call rates (≥90%),
minor allele frequency ≥1%, and no deviation from Hardy-Weinberg
disequilibrium (P<107). Participants were screened for excess het-
erozygosity, sex mismatch, relatedness, and missing data. Individuals of
European descent were considered those within 4 standard deviations
for each of the ﬁrst four genetic principal components of the HapMap
Phase-II Northwestern European population.
2.3.1. Polygenic risk scoring
Genetic risk variants associated with schizophrenia were obtained
from the Psychiatric Genetics Consortium case-control GWAS meta-
analysis (Schizophrenia Working Group of the Psychiatric Genomics
Consortium, 2014). SNPs were clumped according to linkage dis-
equilibrium (LD) in order to obtain the most signiﬁcant SNP per LD-
block (kilobase pair window: 250, LD r2< 0.1). PRS were computed on
imputed genotype data using PRSice (Euesden et al., 2015), by
weighting the mean number of risk alleles against the SNP eﬀect size. P-
value thresholds (Pt) for inclusion of SNPs in the PRS varied between
Pt < 0.0005 and Pt < 1. Scores were standardized to a mean of zero and
standard deviation of one to facilitate interpretation.
PRS for major depressive disorder scores were derived from the
most recent GWAS meta-analysis (Wray et al., 2018). If an association
with the schizophrenia PRS was observed, further analyses with the
major depression risk score were performed to examine speciﬁcity
given the signiﬁcant genetic correlations across psychiatric disorders,
including schizophrenia and depression (Cross-Disorder Group of the
Psychiatric et al. (2013)).
2.4. Hair cortisol
At the age six visit, children were invited with the consent of their
mother to contribute a hair sample for steroid hormone assessment.
Hair samples were cut from the posterior vertex using small surgical
scissors, as close to the scalp as possible. Parents completed a
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questionnaire regarding their child’s use of hair products and corti-
costeroid medications. Steroids were extracted using LC-grade me-
thanol at 25 °C for in the presence of deuterium-labeled steroids as an
internal standard. Samples were centrifuged and cleaned using solid
phase extraction, after which steroids were measured by liquid chro-
matography-tandem mass spectrometry, as previously described (Rippe
et al., 2016). Concentrations of hair cortisol were log-transformed
(Noppe et al., 2015; Rippe et al., 2016).
2.5. Image acquisition
Brain imaging was performed using a 3-T GE MR750w scanner with
an 8-channel head coil, as previously described (White et al., 2018).
Every child was invited to participate in a mock scanning session prior
to the actual brain MRI scan to familiarize them with the scanning
procedure. After a localizer, structural T1 was the ﬁrst sequence, fol-
lowed by the DTI scan. For structural T1 analyses, global metrics of
volume were extracted. T1-weighted images were processed using the
FreeSurfer analysis suite, version 6.0 (Fischl et al., 2004), a widely used
reliable software for brain morphometry processing (Han et al., 2006;
Reuter et al., 2012). Diﬀusion tensor imaging scanning pre-processing
was conducted using the FMRIB Software Library (FSL), version 5.0.9
(Jenkinson et al., 2012). Probabilistic white matter ﬁber tractography
was conducted on DTI images and scalar metrics (i.e. fractional aniso-
tropy [FA], mean diﬀusivity [MD], axial diﬀusivity [AD] and radial
diﬀusivity [RD]) were computed. Global DTI metrics were computed
based on 12 well-studied white matter ﬁber bundles. More detail on
neuroimaging acquisition and quality control is available in the Ap-
pendix.
2.6. Covariates
Age and sex were obtained from study records. Four ancestral
principal components were used as covariates to correct for remaining
population structure. Hair color, hair product use, and corticosteroid
medication use were assessed through parental report.
2.7. Statistical analyses
All analyses were conducted using R statistical software. First, we
examined main eﬀects associations of the schizophrenia PRS with
global brain correlates using linear regression. The outcomes on which
we performed our analyses included cortical and subcortical gray
matter volume, ventricle volume and global FA and MD. Total brain
volume and white mater volume were assessed in secondary analyses.
Therefore, in total we examined seven diﬀerent brain outcomes in the
current study. To address our main aim, whether hair cortisol levels
moderated the relationship between schizophrenia PRS and brain cor-
relates, linear regression with interaction was conducted to test devia-
tion from additivity. The main eﬀects of cortisol and PRS remained
included in the model. All analyses were adjusted for covariates as
described above. Subcortical gray matter volume and ventricular vo-
lumes were assessed as a fraction of intracranial volume to obtain es-
timates relative to head size. Total brain volume, cortical gray matter
volume, and white matter volume were not assessed as a fraction of
intracranial volume due to high correlations with the latter (r=0.93,
r=0.87, and r=0.89, respectively). Analyses involving schizophrenia
PRS were conducted separately for each P-value threshold. For clarity
of presentation, results are shown for schizophrenia risk score
Pt < 0.0005 as this threshold has shown the strongest associations in
previous work from our group (Serdarevic et al., 2018) and in the
current analyses. Results from the other P-value thresholds are shown in
the Appendix A false discovery rate (FDR) correction was applied to
adjust for multiple testing. This was based on the total number of sta-
tistical tests across polygenic scores, cortisol level, P‐value thresholds
and all brain outcomes, resulting in a stringent multiple testing
correction.
Signiﬁcant associations were visually explored in scatter plots. For
simplicity of visualization, hair cortisol level was categorized into two
levels. Interaction graphs were visualized using the ggplot2 package,
and its extension jtools was employed to create Johnson-Neyman plots
for visualization of conﬁdence intervals of diﬀerence between cortisol
levels. Johnson-Neyman plots and intervals indicate the values of the
moderator (hair cortisol) for which the slope of the predictor (PRS) on
the outcome (brain) will be statistically signiﬁcant. Signiﬁcant ob-
servations with the schizophrenia PRS were repeated with the major
depression PRS. Finally, we assessed the relationship between schizo-
phrenia PRS and hair cortisol level, given that an association between
these variables (i.e., gene-environment correlation) would aﬀect the
estimation of gene-environment interaction models.
3. Results
3.1. Sample characteristics
Among the children who used corticosteroids in the 3 months prior
to hair sample collection (Table 1, n=46, 9.2%), the predominant
routes of administration were cutaneous application (n=27, 5.4%).
3.2. Main eﬀects associations
No associations were observed between schizophrenia PRS and
cortical gray matter volume, subcortical gray matter volume, global FA
or global MD (Table 2). Schizophrenia PRS was associated with lower
ventricular volume (Pt < 0.0005: β=-0.13, 95% CI -0.21;-0.04,
P=0.01), but this not survive FDR-correction for multiple testing
(PFDR-adjusted=0.30). Hair cortisol level was not associated with any of
the global gray or white matter measures examined. Neither schizo-
phrenia PRS nor hair cortisol were associated with any of the secondary
outcome measures (Appendix Tables A.1-A.7).
Table 1
Sample characteristics.
N Total population
(N=498)
Child characteristics
Age at MRI, mean (SD) 498 (0%
missing)
9.91 (0.40)
Sex, girls 498 (0%
missing)
47.2
Hair color 498 (0%
missing)
Red 4.8
Blond 84.7
Brown 10.4
Black 0.0
Hair cortisol concentration (pg/mg),
median (IQR)
498 (0%
missing)
1.31 (2.21)
Hair product use on day of hair
collection
498 (0%
missing)
20.7
Corticoid medication use in past 3
months
498 (0%
missing)
9.2
Inhalation 2.6
Intranasal 0.6
Cutaneous 5.4
Oral 0.4
Unknown 0.2
Maternal characteristics
Educational level 478 (4.0%
missing)
High 79.5
Medium 20.5
Low 0.0
Note: numbers represent percentages until stated otherwise.
K. Bolhuis et al. Psychoneuroendocrinology 101 (2019) 295–303
297
3.3. Interaction eﬀects associations
After adjustment for multiple testing, no statistically signiﬁcant
interaction eﬀects were observed for any of the primary or secondary
outcome measures. Nominally signiﬁcant, i.e. uncorrected, estimates
indicated that hair cortisol levels moderated the association between
schizophrenia PRS and ventricle volume (Table 3; Pt < 0.0005:
β=0.10, 95% CI 0.01;0.18, P=0.02), but this did not survive multiple
testing correction (PFDR-adjusted=0.30). Eﬀects were most pronounced
at the lower end of the distribution of schizophrenia PRS (Fig. 1). The
corresponding Johnson-Neyman intervals plot demonstrated that at
values of (log-transformed) cortisol below 0.36, a higher schizophrenia
PRS was nominally associated with a lower ventricle volume. No sig-
niﬁcant associations were observed for cortisol levels above 0.36.
Hair cortisol moderated the association between schizophrenia risk
score and global MD (Appendix Table A.7, Pt< 0.0005: β=0.10, 95%
CI 0.02;0.19, P=0.01); again this ﬁnding did not survive correction for
multiple testing (PFDR-adjusted=0.30). Fig. 2 demonstrates nominally
signiﬁcant relationships at both ends of the cortisol distribution. The
Neyman-Johnson plot indicates that at values of (log-transformed) hair
cortisol below -0.01 and above 1.32, schizophrenia PRS was associated
with global MD in a negative and a positive direction, respectively.
Higher cortisol in combination with elevated polygenic risk was asso-
ciated with higher global MD. Accordingly, lower cortisol in combina-
tion with higher polygenic risk was associated with lower global MD.
3.4. Follow-up analyses with global AD and RD
No main eﬀect was observed between either PRS or hair cortisol and
global AD or RD (Appendix Table A.8-A.9). A nominal interaction was
observed between hair cortisol and schizophrenia PRS on both global
AD (Pt< 0.0005: β=0.10, 95% CI 0.02;0.18, P=0.02) and global RD
(Pt< 0.0005: β=0.09, 95% CI 0.01;0.17, P=0.04). A higher schizo-
phrenia PRS in combination with high cortisol was associated with
higher global AD (Appendix Figure A.2). This was consistent with the
ﬁnding for RD, which showed a diﬀerent direction reﬂecting the reverse
correlation with other white matter parameters; a lower polygenic risk
in combination with lower hair cortisol was associated with higher
global RD (Appendix Figure A.3).
3.5. Sensitivity analyses with depression polygenic risk
No signiﬁcant interaction eﬀect was observed between hair cortisol
level and major depressive disorder polygenic risk on brain ventricle
volume or global MD (Appendix Table A.10-A.11). Post-hoc power
analysis for multiple regression with total brain volume as the outcome
(Soper, 2018), using the following parameters: number of pre-
dictors= 11; observed R2= 0.29; P-value for interaction=0.89;
sample size= 498, yielded an observed statistical power of 100%. With
only hair cortisol and schizophrenia PRS included in the calculation and
a resulting R2=0.01 and P= 0.73, resulted in a statistical power es-
timation of 97%.
Table 2
Main eﬀects of schizophrenia polygenic risk score (upper panel) and hair cortisol (lower panel) on global structural volumetric and global white matter
microstructural measures.
Outcome β (95% CI) P PFDR-adjusted
Schizophrenia polygenic risk
Structural volumetric measures (N=498)
Cortical gray matter volume −0.04 (-0.12;0.04) 0.32 0.62
Subcortical gray matter volume 0.02 (-0.07;0.10) 0.68 0.84
Total ventricle volume −0.13 (-0.21;-0.04) 0.01 0.30
White matter microstructural measures (N=526)
Global fractional anisotropy (FA) 0.05 (-0.03;0.14) 0.24 0.53
Global mean diﬀusivity (MD) −0.05 (-0.13;0.04) 0.29 0.58
Hair cortisol
Structural volumetric measures (N=498)
Cortical gray matter volume 0.00 (-0.08;0.08) 0.96 0.98
Subcortical gray matter volume 0.07 (-0.02;0.16) 0.11 0.81
Total ventricle volume −0.06 (-0.15;0.03) 0.19 0.48
White matter microstructural measures (N=526)
Global fractional anisotropy (FA) 0.04 (-0.04;0.13) 0.33 0.62
Global mean diﬀusivity (MD) 0.01 (-0.07;0.10) 0.73 0.85
Note: Results are shown for the P-value threshold Pt< 0.0005. Models were adjusted for age at MRI visit and child sex, hair color, hair product use, corti-
costeroid use, and 4 principal components. Subcortical gray matter volume and total ventricular volume were assessed as a fraction of intracranial volume. False
discovery rate correction for multiple testing was based on the total number of statistical tests across main eﬀects of both polygenic scores and cortisol, P‐value
thresholds and brain outcomes. Abbreviations: PFDR-adjsuted, false-discovery rate corrected P-value.
Table 3
Interaction eﬀect of hair cortisol levels and schizophrenia polygenic risk score on global structural volumetric and global white matter microstructural mea-
sures.
Outcome β (95% CI) P PFDR-adjusted
Structural volumetric measures (N=498)
Cortical gray matter volume 0.03 (-0.05;0.10) 0.52 0.76
Subcortical gray matter volume −0.02 (-0.10;0.06) 0.62 0.81
Total ventricle volume 0.10 (0.01;0.18) 0.02 0.30
White matter microstructural measures (N=526)
Global fractional anisotropy (FA) −0.04 (-0.12;0.05) 0.37 0.64
Global mean diﬀusivity (MD) 0.10 (0.02;0.19) 0.01 0.30
Note: Results are shown for the P-value threshold Pt< 0.0005. All models all included the main eﬀects and the interaction term. Models were adjusted for age at
MRI visit and child sex, hair color, hair product use, corticosteroid use, and 4 principal components. Subcortical gray matter volume and total ventricular
volume were assessed as a fraction of intracranial volume. Abbreviations: PFDR-adjsuted, false-discovery rate corrected P-value.
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3.6. Association between schizophrenia vulnerability and hair cortisol
No association was observed between schizophrenia PRS and hair
cortisol level (Table 4).
4. Discussion
In this population-based neuroimaging study in pre-adolescents, we
examined whether hair cortisol levels moderated the relationship of
schizophrenia PRS with brain structural morphology or white matter
microstructure. When stringently corrected for multiple testing across
polygenic risk score P-value thresholds for all primary and secondary
neuroimaging outcome measures, no signiﬁcant main or interaction
associations were observed. Analyses uncorrected for multiple testing
should therefore be interpreted with caution. Uncorrected associations
suggested that high cortisol in combination with elevated genetic risk
for schizophrenia was related to lower white matter microstructure, and
that low cortisol in combination with low schizophrenia PRS was as-
sociated with larger cerebral ventricles. These associations were was
Fig. 1. Relationship between schizophrenia polygenic risk score (PRS) and total ventricular volume as a function of hair cortisol level (left) and corresponding
Johnson-Neyman plot (right).
Note: For simplicity of visualization, hair cortisol level was categorized into two levels: high (n=66), one standard deviation above the total sample mean; average-
low (n=428), one standard deviation above mean and lower. The gray-shaded areas denote 95% conﬁdence intervals. P-value threshold for the schizophrenia PRS is
shown at Pt < 0.0005. Both schizophrenia PRS (x-axis) and total ventricle volume (y-axis) are standardized. Total ventricle volume was taken as a fraction of total
intracranial volume. The right graph shows the Johnson-Neyman plots, which indicates at values of (log-transformed) cortisol below 0.36, the slope of schizophrenia
PRS is signiﬁcantly diﬀerent from zero, and negative (turquoise shaded area).
Fig. 2. Relationship between schizophrenia polygenic risk score (PRS) and global mean diﬀusivity as a function of hair cortisol level (left) and corresponding
Johnson-Neyman plot (right).
Note: For simplicity of visualization, hair cortisol level was categorized into two levels: low (n=75), one standard deviation below the total sample mean; average-
high (n=451), one standard deviation below the mean and higher. The gray-shaded areas denote 95% conﬁdence intervals. P-value threshold for the schizophrenia
PRS is shown at Pt < 0.0005. Both schizophrenia PRS (x-axis) and global mean diﬀusivity (y-axis) are standardized. The right graph shows the Johnson-Neyman
plots, which indicates at values of (log-transformed) cortisol below -0.01 and above 1.32, the slope of schizophrenia PRS is signiﬁcantly diﬀerent from zero, and
negative respectively positive (turquoise shaded area).
Table 4
Association between schizophrenia polygenic risk scores and hair cortisol le-
vel.a.
P-value threshold Number of SNPsb β (95% CI) P
Pt < 0.0005 2 965 −0.03 (-0.12;0.06) 0.53
Pt < 0.001 4 148 −0.04 (-0.13;0.05) 0.42
Pt < 0.005 9 547 −0.02 (-0.11;0.07) 0.59
Pt < 0.01 13 916 0.01 (-0.10;0.08) 0.76
Pt < 0.05 34 947 −0.02 (-0.11;0.07) 0.70
Pt < 0.1 52 256 0.00 (-0.09;0.09) 0.96
Pt < 0.5 126 674 0.00 (-0.09;0.09) 1.00
Pt < 1.0 164 190 0.00 (-0.09;0.09) 0.97
Note: Models are adjusted for child age at hair sample collection, child sex, hair
color, hair product use and 4 ancestral principal components. SNPs were
clumped prior to calculation of the polygenic score. Abbreviations: Pt, P-value
threshold; SNP, single nucleotide polymorphism.
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not observed for the depression PRS, possibly suggesting speciﬁcity
with regard to schizophrenia genetic liability. Although our ﬁndings are
suggestive, they are potentially informative in the contextualization of
the genetic and environmental determinants of pre-adolescent brain
structure, particularly against the background of chronic stress ex-
posure as a moderating inﬂuence on disease-related brain pathophy-
siology through schizophrenia PRS.
Enlarged ventricular volume and lower white matter integrity are
among the most well-established and largest eﬀect size neurobiological
ﬁndings in adult patients with schizophrenia, as conﬁrmed by recent
meta-analyses (Brugger and Howes, 2017; Kelly et al., 2018; van Erp
et al., 2016). However, it has been diﬃcult to disentangle the eﬀects of
confounding factors, most notably illness course and antipsychotic
medication (Van Haren et al., 2013). Against this background, our
ﬁndings in pre-adolescents without a diagnosis of a psychotic disorder
provide novel hypotheses into the complex interplay of genetic and
environmental determinants in inﬂuencing schizophrenia pathophy-
siology (Belbasis et al., 2018). We observed suggestive associations in
which hair cortisol moderated the association between high polygenic
risk for schizophrenia and brain structure, although these associations
did not survive the correction for multiple testing. These suggestive
ﬁndings might also help to explain the previous null ﬁndings arising
from studies examining the brain structural correlates of schizophrenia
PRS (Papiol et al., 2014; Van der Auwera et al., 2015, 2017), as the
underlying eﬀects might have been obscured by the interacting inﬂu-
ence of environmental determinants. Accordingly, our ﬁndings high-
light the importance of integrating genetic and environmental risk
factors in order to better understand the pathophysiology of psychiatric
illness (van Os et al., 2010). Additional environmental determinants
should also be studied in the context of (polygenic) gene by environ-
ment interaction studies. For example, recent evidence has indicated
that elevated schizophrenia genetic risk is associated with a higher rate
of obstetric complications (Ursini et al., 2018). In this regard, pro-
spective longitudinal neuroimaging and follow-up assessments of mul-
tiple environmental risks would provide a powerful study design for
disentangling critical windows of neurodevelopment.
Our analyses did not observe any main association between schi-
zophrenia PRS and structural brain volumes or white matter micro-
structure. This is largely consistent with previous studies exploring
main eﬀects of genetic risk on brain structure (Papiol et al., 2014; Van
der Auwera et al., 2015, 2017), although a few studies have reported
neuroimaging correlates of schizophrenia genetic risk (Fonville et al.,
2018; Liu et al., 2017; Terwisscha van Scheltinga et al., 2013). More-
over, the absence of signiﬁcant hair cortisol by polygenic risk interac-
tion eﬀects might be explained by the relatively small sample size of
this study and the relatively young age of the cohort. Larger samples
with more power will be needed to detect small eﬀects in pre-adoles-
cence. Further, the joint eﬀects of stress hormone levels and genetic risk
for schizophrenia on brain structure might only become apparent when
prodromal symptoms become apparent during adolescence as opposed
to earlier in childhood development prior to the symptoms onset.
However, it should be noted that schizophrenia PRS has been associated
with psychiatric problems in the general pediatric population from as
young as 3 years of age (Jansen et al., 2018), and infant neuromotor
development at 9 months of age (Serdarevic et al., 2018), suggesting
that the genetic risk for schizophrenia has neurobiological manifesta-
tions from early childhood onwards. Furthermore, the schizophrenia
PRS explains approximately 7% of variation in the original GWAS
(Schizophrenia Working Group of the Psychiatric Genomics
Consortium, 2014), so it can be expected that the explained variance is
much lower in an unrelated sample, much younger age group and a
quite diﬀerent outcome measure. In addition, functional neuroimaging
modalities might be more sensitive to detect subtle neurobiological
changes associated with early life genetic risk for schizophrenia
(Lancaster et al., 2016). More importantly, it has been noted that in-
teraction testing with PRS might not be ideal as risk scores assume
genetic additivity and some, but not all, of the SNPs in the risk score
might be involved in the interaction to various degrees and, potentially,
in opposing directions (i.e. some but not all variants might follow a
pattern of diﬀerential susceptibility) (Peyrot et al., 2017; Zwicker et al.,
2018). Another avenue for gene-environment-interaction research is to
employ biologically informed multi-locus proﬁle scores, which are
composites of genetic polymorphisms from a given neural signaling
pathway (Bogdan et al., 2017), and examine how these diﬀerentially
associate with environmental factors (Zwicker et al., 2018).
Although no signiﬁcant associations were observed after correction
for multiple testing, our uncorrected suggestive ﬁndings provide novel
hypotheses about schizophrenia’s pathophysiology. Interestingly, and
somewhat paradoxically, we found that in children with low cortisol
levels, reduced schizophrenia genetic liability was associated with
larger ventricles. Furthermore, the combination of low genetic risk for
schizophrenia and high cortisol levels was associated with lower ven-
tricular volume. These seemingly incongruous observations should be
evaluated in the context of brain development throughout the ﬁrst
years of life. Although larger cerebral ventricles have been strongly
associated with schizophrenia in clinical samples (Brugger and Howes,
2017), longitudinal cohort studies from the general population indicate
that brain ventricles increase in size with advancing childhood devel-
opment (Lenroot and Giedd, 2006), for which relative brain ventricular
enlargement has also been associated with adaptive outcomes in
childhood, such as fetal growth maturation (Gilmore et al., 2018; Roza
et al., 2008b). Indeed, some studies have indicated that lower ven-
tricular volume is associated with worse behavioral outcomes in
childhood, such as temperamental diﬃculties (Roza et al., 2008a), and
attention-deﬁcit/hyperactivity disorder (Castellanos et al., 1996). Brain
ventricles have been reported to have the highest variability of brain
morphometric structures, possibly since they verge on many other brain
structures (Gilmore et al., 2018). These observations contrast with
ﬁndings from clinical samples of adults with schizophrenia, which have
robustly implicated larger cerebral ventricles in the neurobiological
pathophysiology of schizophrenia (Brugger and Howes, 2017; van Erp
et al., 2016), a ﬁnding that has also been extended to samples of
childhood-onset schizophrenia (Rapoport et al., 1997). Against this
background, reports of increased ventricular volume in the context of
neuropsychiatric conditions should therefore be interpreted with cau-
tion. Further research across distinct sampling designs and neurode-
velopmental stages are needed to examine how these seemingly con-
tradictory observations relate to the neurodevelopmental risk of
schizophrenia (Murray et al., 2017).
White matter microstructural integrity increases in normal child-
hood and adolescence (Di Martino et al., 2014), i.e. FA increases and
diﬀusion indices (MD, AD and RD) decrease with age. Lower FA and
higher diﬀusion metrics, in particular MD, have been observed across
several brain regions in patients with schizophrenia (Kelly et al., 2018).
This is consistent with our observation of increased MD in children with
elevated genetic risk for schizophrenia who also had high cortisol le-
vels, even though this association did not survive correction for mul-
tiple testing. No such moderation eﬀect was seen for FA, which we had
hypothesized given the lower FA commonly observed in persons with
schizophrenia (Kelly et al., 2018). However, few studies have com-
prehensively examined FA in conjunction with diﬀusion metrics, which
is important for future research to disentangle neurobiological me-
chanisms. When viewed from the perspective of ventricle volume and
white matter microstructure, it appears that the optimal level of stress
exposure varies between children as a function of their genetic risk.
Over the past several years, hair cortisol has gained increasing at-
tention as a biological marker of chronic physiological stress, which is
interesting considering the hypothalamic-pituitary-adrenal-axis in-
volvement in schizophrenia. Consistent with prior work from our
group, our current results did not identify main eﬀect associations be-
tween hair cortisol and brain structure (Chen et al., 2016). In addition,
schizophrenia PRS was not associated with hair cortisol in the current
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sample, consistent with previous research demonstrating a low SNP
heritability (Neumann et al., 2017), and potentially reﬂecting the large
environmental component of hair cortisol assessments. Rather, we
found suggestive evidence for hair cortisol moderating the association
of schizophrenia PRS with ventricle volume and global MD. Results
from an earlier twin study had already hinted that the association of
salivary cortisol with brain correlates might be at least partially de-
termined by genetic factors (Kremen et al., 2010), further supporting
our ﬁnding that genetic predisposition is a potential consideration in
the association between environmental stressors and brain structure.
The strengths of this study included the use of exclusively biological
metrics for examining determinants of psychiatric pathophysiology, its
prospective design, and the population-based sample. However, our
sample was not large enough to detect small eﬀects, potentially in-
creasing the chances of false negatives. However, the Generation R
Study is the largest pre-adolescent neuroimaging study to date, so al-
though our analyses might be underpowered, we are working with the
best data available. Large collaborative eﬀorts will be needed to further
examine how increased genetic risk for psychiatric disorders aﬀect
neurodevelopment. Relatedly, the current sample size was relatively
small compared with other Generation R studies using genotype data
(Serdarevic et al., 2018), which might indicate a potential selective loss
to follow-up. Although non-participation in population-based cohort
studies has been related to higher schizophrenia PRS (Martin et al.,
2016), our attrition analyses demonstrated no group diﬀerences in PRS
between participants with complete data and participants lost to follow-
up. Furthermore, we did not have imaging and hair cortisol data
available at both ages six and ten years to study their relative pro-
spective relationships. However, we have previously shown an absence
of a statistical interaction between hair cortisol and the time interval
between hair sampling and MRI scanning (Chen et al., 2016). In addi-
tion, cortisol measures, even if performed in hair, could reﬂect tem-
porary states of stress. However, hair cortisol levels exhibit high intra-
subject stability (Stalder et al., 2012) and have been demonstrated to
reﬂect chronic exposure to stress (Rippe et al., 2016; Stalder et al.,
2017). And, from a neurodevelopmental perspective, whether hair
cortisol at age 6 years reﬂects stress at age 10 years is less relevant,
because the neurodevelopmental process giving rise to a change in
brain structure must necessarily have occurred long before age 10
years. In addition, similar to many other genetic studies, our analyses
were limited to children of European descent. Future large psychiatric
GWAS eﬀorts should prioritize genetic discovery among a wide di-
versity of ethnic backgrounds, and not only focus on people of Eur-
opean ancestry. Finally, this was an observational study, which limits
inferences regarding the purported causality of our observations. Long-
term follow-up of this population into adolescence will provide us with
the opportunity to examine how these observations relate to the onset
of prodromal symptomatology.
5. Conclusions
In summary, following stringent correction for multiple testing, we
found no signiﬁcant moderating eﬀects of hair cortisol on the associa-
tion between schizophrenia PRS and pre-adolescent brain structure,
precluding any ﬁrm conclusions regarding the interaction between
schizophrenia PRS and hair cortisol on neuroimaging outcomes in pre-
adolescence. We obtained statistically suggestive evidence that hair
cortisol levels moderated the relationship of schizophrenia PRS with
brain ventricular volume and white matter microstructure. Such ob-
servations potentially attest to the importance of considering the in-
teraction between genetic and environmental determinants in psy-
chiatric disease pathophysiology.
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